NCT03500497

Brief Summary

During a period of a year, reticulocyte hemoglobin content (RetHe) measurements (Sysmex) are done out of blood samples taken on several occasions during normal patient care:

  1. 1.preoperatively at the surgical or anesthetic outpatient visit
  2. 2.on admission or pre- induction of anesthesia
  3. 3.postoperatively at the postanesthetic care unit
  4. 4.on day 3 postoperatively
  5. 5.on day 5 postoperatively

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
164

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 25, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 14, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 18, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 7, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 2, 2019

Completed
Last Updated

January 4, 2019

Status Verified

January 1, 2019

Enrollment Period

1.2 years

First QC Date

February 14, 2018

Last Update Submit

January 2, 2019

Conditions

Keywords

reticulocyte hemoglobin content (RetHe)perioperativecolorectal surgeryanemia

Outcome Measures

Primary Outcomes (1)

  • Change of RetHe measurement

    To assess the change of RetHe measurement from baseline (preoperative assessment) to different points in time in standard care (i.e. RetHe measurement at day of admission, direct postoperatively and day 3 and 5 postoperatively)

    From baseline to 60 days postoperatively

Secondary Outcomes (3)

  • Relation of RetHe to standard iron status measurements

    1 year

  • Perioperative complications

    Days of admission

  • Quality of life measurement preoperatively and 30-days postoperatively

    From baseline to 30-days postoperatively

Interventions

RetHe measurement is done from blood samples gained during standard patient care perioperatively

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

elective colorectal surgery patients (cancer surgery, inflammatory disease, other pathologies needing elective intestinal surgery)

You may qualify if:

  • All adult patients (≥ 18 years) scheduled for colorectal surgical operations (laparoscopic and open procedures)

You may not qualify if:

  • emergency surgery
  • minors and incapacitated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MUMC

Maastricht, Limburg, Netherlands

Location

Related Publications (16)

  • Aapro M, Osterborg A, Gascon P, Ludwig H, Beguin Y. Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Ann Oncol. 2012 Aug;23(8):1954-1962. doi: 10.1093/annonc/mds112. Epub 2012 May 9.

    PMID: 22575608BACKGROUND
  • Archer NM, Brugnara C. Diagnosis of iron-deficient states. Crit Rev Clin Lab Sci. 2015;52(5):256-72. doi: 10.3109/10408363.2015.1038744. Epub 2015 Aug 14.

    PMID: 26292073BACKGROUND
  • Clevenger B, Richards T. Pre-operative anaemia. Anaesthesia. 2015 Jan;70 Suppl 1:20-8, e6-8. doi: 10.1111/anae.12918.

    PMID: 25440391BACKGROUND
  • Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM. The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial. Ann Surg. 2016 Jul;264(1):41-6. doi: 10.1097/SLA.0000000000001646.

    PMID: 26817624BACKGROUND
  • Gozzard D. When is high-dose intravenous iron repletion needed? Assessing new treatment options. Drug Des Devel Ther. 2011 Jan 20;5:51-60. doi: 10.2147/DDDT.S15817.

    PMID: 21340038BACKGROUND
  • Herrera-deGuise C, Casellas F, Robles V, Navarro E, Borruel N. Iron Deficiency in the Absence of Anemia Impairs the Perception of Health-Related Quality of Life of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 Jun;22(6):1450-5. doi: 10.1097/MIB.0000000000000768.

    PMID: 27057682BACKGROUND
  • Jans O, Bandholm T, Kurbegovic S, Solgaard S, Kjaersgaard-Andersen P, Johansson PI, Kehlet H; Lundbeck Foundation Centre for Fast-Track Hip and Knee Replacement Collaborative Group. Postoperative anemia and early functional outcomes after fast-track hip arthroplasty: a prospective cohort study. Transfusion. 2016 Apr;56(4):917-25. doi: 10.1111/trf.13508. Epub 2016 Mar 4.

    PMID: 26945552BACKGROUND
  • Kanuri G, Sawhney R, Varghese J, Britto M, Shet A. Iron Deficiency Anemia Coexists with Cancer Related Anemia and Adversely Impacts Quality of Life. PLoS One. 2016 Sep 28;11(9):e0163817. doi: 10.1371/journal.pone.0163817. eCollection 2016.

    PMID: 27682226BACKGROUND
  • Keeler BD, Mishra A, Stavrou CL, Beeby S, Simpson JA, Acheson AG. A cohort investigation of anaemia, treatment and the use of allogeneic blood transfusion in colorectal cancer surgery. Ann Med Surg (Lond). 2015 Dec 22;6:6-11. doi: 10.1016/j.amsu.2015.12.052. eCollection 2016 Mar.

    PMID: 26909150BACKGROUND
  • Beale AL, Penney MD, Allison MC. The prevalence of iron deficiency among patients presenting with colorectal cancer. Colorectal Dis. 2005 Jul;7(4):398-402. doi: 10.1111/j.1463-1318.2005.00789.x.

    PMID: 15932566BACKGROUND
  • Mast AE, Blinder MA, Dietzen DJ. Reticulocyte hemoglobin content. Am J Hematol. 2008 Apr;83(4):307-10. doi: 10.1002/ajh.21090.

    PMID: 18027835BACKGROUND
  • Mouysset JL, Freier B, van den Bosch J, Levache CB, Bols A, Tessen HW, Belton L, Bohac GC, Terwey JH, Tonini G. Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study. Cancer Manag Res. 2016 Jan 21;8:1-10. doi: 10.2147/CMAR.S88110. eCollection 2016.

    PMID: 26855598BACKGROUND
  • Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, Soweid A, Hoballah JJ, Taher AT, Jamali FR. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011 Oct 15;378(9800):1396-407. doi: 10.1016/S0140-6736(11)61381-0. Epub 2011 Oct 5.

    PMID: 21982521BACKGROUND
  • So-Osman C, Nelissen R, Brand R, Brand A, Stiggelbout AM. Postoperative anemia after joint replacement surgery is not related to quality of life during the first two weeks postoperatively. Transfusion. 2011 Jan;51(1):71-81. doi: 10.1111/j.1537-2995.2010.02784.x.

    PMID: 20663113BACKGROUND
  • Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T, Cavill I; British Committee for Standards in Haematology. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol. 2013 Jun;161(5):639-648. doi: 10.1111/bjh.12311. Epub 2013 Apr 10. No abstract available.

    PMID: 23573815BACKGROUND
  • Urrechaga E, Borque L, Escanero JF. Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis. Biomed Res Int. 2013;2013:603786. doi: 10.1155/2013/603786. Epub 2013 Feb 28.

    PMID: 23555091BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood samples

MeSH Terms

Conditions

Anemia

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Cornelia S Mueller, Dr

    MUMC Maastricht

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2018

First Posted

April 18, 2018

Study Start

August 25, 2017

Primary Completion

November 7, 2018

Study Completion

January 2, 2019

Last Updated

January 4, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Data will be handled confidentially. Patients included in the study will be given a random study identification code that is not based on the patients' birth date or initials. One way coding using ascending numbers will be used. Access to the coding system is only granted to the investigators.

Locations